Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aurinia Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AUPH
Nasdaq
2834
www.auriniapharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aurinia Pharmaceuticals Inc.
Earnings Beat May Change The Case For Aurinia Pharmaceuticals Stock
- Nov 6th, 2026 3:15 am
Aurinia Pharmaceuticals (AUPH) Tops Q3 Earnings Estimates
- Oct 30th, 2026 6:05 am
Aurinia: Q3 Earnings Snapshot
- Oct 30th, 2026 6:04 am
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Provides Update on Recent Business Progress
- Oct 30th, 2026 6:00 am
Earnings Preview: Ionis Pharmaceuticals (IONS) Q3 Earnings Expected to Decline
- Oct 28th, 2026 7:00 am
Earnings Preview: Aurinia Pharmaceuticals (AUPH) Q3 Earnings Expected to Decline
- Oct 27th, 2026 7:00 am
Aurinia’s (AUPH) Profits Surge While Its One Drug Just Got Company
- Sep 15th, 2026 11:13 pm
Immatics and 4 More Stocks See Action From Activist Investors
- Sep 4th, 2026 4:59 pm
Could Aurinia Pharmaceuticals (AUPH) Stock Win Big After its LUPKYNIS Patent Settlement With Teva Pharmaceuticals (TEVA)?
- Aug 28th, 2026 3:14 pm
How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback
- Aug 20th, 2026 1:11 am
Aurinia Pharmaceuticals (AUPH) Stock Still Looks Cheap After A 74% Gain
- Aug 19th, 2026 6:16 pm
AUPH Stock Rallies 6% After-Hours — Here’s Why
- Aug 19th, 2026 4:15 pm
Aurinia Settles Patent Litigation with Teva
- Aug 19th, 2026 2:05 pm
Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates
- Aug 6th, 2026 7:50 am
Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress
- Aug 6th, 2026 6:00 am
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Lags Revenue Estimates
- Aug 5th, 2026 7:55 am
Karyopharm Therapeutics (KPTI) Soars 5.3%: Is Further Upside Left in the Stock?
- Jul 22nd, 2026 5:40 am
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
- Jul 6th, 2026 6:00 am
Aurinia (AUPH) Upgraded to Strong Buy: Here's Why
- Jul 2nd, 2026 10:00 am
Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now?
- Jun 29th, 2026 2:07 pm
Scroll